Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|October 28, 2025
Optimization of Species-Selective Reversible Proteasome Inhibitors for the Treatment of MalariaSuraksha Gahalawat, Sneha Ray, Xiaoyu Zhang, et al.
European Journal of Medicinal Chemistry|July 18, 2024
Optimization of pyrazolopyridine 4-carboxamides with potent antimalarial activity for which resistance is associated with the P. falciparum transporter ABCI3Petar P S Calic, Trent D Ashton, Mahta Mansouri, et al.
ACS Omega|September 29, 2025
Screening of Medicines for Malaria Venture Open Boxes Identifies Potent SARS-CoV‑2 Papain-like Protease (PL<sup>pro</sup>) InhibitorsVictor Oliveira Gawriljuk, Gabriela Dias Noske, Rafaela Sachetto Fernandes, et al.
Nature Communications|May 27, 2023
Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparumKrittikorn Kümpornsin, Theerarat Kochakarn, Tomas Yeo, et al.
Nature Communications|March 17, 2023
Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formationSelina Bopp, Charisse Flerida A Pasaje, Robert L Summers, et al.
Journal of Medicinal Chemistry|September 18, 2020
Synthesis and Structure-Activity Relationship of Dual-Stage Antimalarial Pyrazolo[3,4-<i>b</i>]pyridinesScott Eagon, Jared T Hammill, Martina Sigal, et al.
Cell Chemical Biology|July 7, 2021
The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistanceJames M Murithi, Ioanna Deni, Charisse Flerida A Pasaje, et al.
Journal of Medicinal Chemistry|December 23, 2024
Structure-Based Discovery and Development of Highly Potent Dihydroorotate Dehydrogenase Inhibitors for Malaria ChemopreventionZhe Nie, Roger Bonnert, Jet Tsien, et al.
Pageof 7